Dr. Leonard Saltz of Memorial Sloan-Kettering Cancer Center discusses the magnitude of the growing costs for the new targeted cancer drugs. He gives his opinion how this has developed and puts it in perspective.
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3573
RSS feed for comments on this post.